Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Cancer Discov. 2011 Jun 17;1(3):248–259. doi: 10.1158/2159-8290.CD-11-0085

Figure 6. Addition of an AKT inhibitor to AZD8055 promotes apoptosis in BT-474 cells.

Figure 6

(A) BT-474 cells were treated with either 500nM of AZD8055 or 2μM of an AKT inhibitor or the combination for forty-eight hours. The fraction of apoptotic cells (sub-G1) was determined by flow cytometry. (B) BT-474 cells were collected after twenty-four hours of treatment and the lysates were analyzed by immunoblotting.

HHS Vulnerability Disclosure